OR WAIT null SECS
Jill Wechsler is Pharmaceutical Technology's Washington Editor, jillwechsler7@gmail.com.
February 24, 2015
Drug shortages are declining, but they’re still a serious concern for regulatory authorities, policy makers, and bio/pharmaceutical manufacturers.
February 17, 2015
The ongoing battle over drug reimbursement and pricing has raised questions about whether the pharmaceutical industry can continue to rely on high United States revenues to fund biopharmaceutical R&D.
February 11, 2015
The Center for Drug Evaluation and Research seeks a more flexible system for assessing biotech product quality.
The industry reacts to the departure of Commissioner Margaret Hamburg.
February 03, 2015
President Obama unveils his “Precision Medicine Initiative”.
February 02, 2015
Manufacturers face new rules for tracing drugs through the supply chain and compounders face stricter standards.